These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1373406)

  • 1. Mapping of functional regions of Clostridium perfringens type A enterotoxin.
    Hanna PC; Wieckowski EU; Mietzner TA; McClane BA
    Infect Immun; 1992 May; 60(5):2110-4. PubMed ID: 1373406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides.
    Sugii S
    J Vet Med Sci; 1994 Dec; 56(6):1047-50. PubMed ID: 7535106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion analysis of the Clostridium perfringens enterotoxin.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1997 Mar; 65(3):1014-22. PubMed ID: 9038311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.
    Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA
    Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative and Highly Sensitive Detection of
    Neumann T; Krüger M; Weisemann J; Mahrhold S; Stern D; Dorner MB; Feraudet-Tarisse C; Pöhlmann C; Schulz K; Messelhäußer U; Rimek D; Gessler F; Elßner T; Simon S; Rummel A; Dorner BG
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917845
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of Clostridium perfringens enterotoxin.
    McClane BA
    Toxicon; 1996; 34(11-12):1335-43. PubMed ID: 9027990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions.
    McClane BA
    Toxicon; 2001 Nov; 39(11):1781-91. PubMed ID: 11595640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.
    Hanna PC; McClane BA
    Mol Microbiol; 1991 Jan; 5(1):225-30. PubMed ID: 2014001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypsin activation of enterotoxin from Clostridium perfringens type A: fragmentation and some physicochemical properties.
    Granum PE; Whitaker JR; Skjelkvåle R
    Biochim Biophys Acta; 1981 May; 668(3):325-32. PubMed ID: 6165395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxicity induced by Clostridium perfringens isolate carrying a chromosomal cpe gene is exclusively dependent on sporulation and enterotoxin production.
    Yasugi M; Sugahara Y; Hoshi H; Kondo K; Talukdar PK; Sarker MR; Yamamoto S; Kamata Y; Miyake M
    Microb Pathog; 2015 Aug; 85():1-10. PubMed ID: 25912832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.
    Arabshahi S; Nayeri Fasaei B; Derakhshandeh A; Novinrooz A
    Bioengineered; 2018 Jan; 9(1):170-177. PubMed ID: 29091543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.
    Smedley JG; Uzal FA; McClane BA
    Infect Immun; 2007 May; 75(5):2381-90. PubMed ID: 17307943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis.
    Smedley JG; McClane BA
    Infect Immun; 2004 Dec; 72(12):6914-23. PubMed ID: 15557612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens type A enterotoxin (CPE): more than just explosive diarrhea.
    Lindsay JA
    Crit Rev Microbiol; 1996; 22(4):257-77. PubMed ID: 8989513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of functional regions of Clostridium perfringens enterotoxin through deletion analysis.
    Kokai-Kun JF; McClane BA
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S165-7. PubMed ID: 9310665
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of an Important Orphan Histidine Kinase for the Initiation of Sporulation and Enterotoxin Production by
    Freedman JC; Li J; Mi E; McClane BA
    mBio; 2019 Jan; 10(1):. PubMed ID: 30670619
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes.
    McClane BA
    Toxicology; 1994 Feb; 87(1-3):43-67. PubMed ID: 8160188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.
    Chen J; Theoret JR; Shrestha A; Smedley JG; McClane BA
    Infect Immun; 2012 Dec; 80(12):4078-88. PubMed ID: 22966051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.